Clinical Trial Update: Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating intensified radiation delivered via accelerated hypofractionated IMRT with concurrent carboplatin and paclitaxel for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Esophagus Cancer, Esophageal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING